FdaApplication
ANDA 212430
Identifiers
- fda_app_no: ANDA212430
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMAZONE |
| application_type | ANDA |
| approval_date | 2026-03-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RIFABUTIN | RIFABUTIN | 150MG | CAPSULE;ORAL |
1 product